FrontPage is India's Stock Market Social Network
Join 3,00,000+ Traders and Investors
BIOCON
201234567898012345678920123456789.1012345678950123456789
+7.70 (+2.81%)
Previous Close: 274.45
1D
5D
1M
3M
1Y
5Y
Popular Posts

Santosh Swing Trade Coach

Valid CHARTS

Being Trader

Being Trader

Rahul Bora

ChartArt TA

Adhithya

Adhithya

Bull News : US Fed says no Recession will come, Biggest gain of Nasdaq in single day. Fed rate hike by 0.75% #BAJFINANCE profit rise 159%. Bajaj FinServ going to split and going to give Bonus. #BIOCON profit rise 71.4% #UBL profit rise 422.5% #DIXON profit rise 150% #NIFTY50 Chemical, Finance, Pharma, Textile stocks will go upside today.

Kishore kumar Ganta

Results on July 28 Dr Reddy's Laboratories, Nestle India, SBI Life Insurance Company, Shree Cement, Jubilant FoodWorks, Vedanta, Bajaj Finserv, Punjab National Bank, Mahindra & Mahindra Financial Services, PNB Housing Finance, SBI Cards and Payment Services, TVS Motor Company, Shriram Transport Finance, Chalet Hotels, Equitas Small Finance Bank, CMS Info Systems, GHCL, AAVAS Financiers, Intellect Design Arena, Dr Lal PathLabs, Motilal Oswal Financial Services, Nippon Life India Asset Management, NIIT, NOCIL, RITES, Sona BLW Precision Forgings, TTK Prestige, and Westlife Development will be in focus ahead of June quarter earnings on July 28. Stocks in News Tata Motors: The company posted consolidated loss at Rs 5,006.6 crore for the quarter ended June 2022, widening from loss of Rs 4,450.92 crore in same period last year on account of weak JLR performance. Consolidated revenue from operations grew by 8.3% YoY to Rs 71,934.66 crore during the same period, driven by domestic business. Jaguar Land Rover revenue declined 7.6% QoQ and 11.3% YoY to 4.4 billion pound impacted by semiconductor shortages and China lockdowns, but customer order book grew further to 2 lakh vehicles. Welspun India: The company has reported a 11.6% year-on-year decline in consolidated revenue at Rs 1,957.3 crore for the quarter ended June 2022, impacted by home textile business but flooring business fared better. Profit fell sharply by 90.4% to Rs 21.36 crore on weak operating performance at home textile business. Biocon: The pharma company recorded a 54.4% YoY growth in consolidated profit at Rs 167.40 crore for the quarter ended June 2022, partly aided by higher revenue & other income and lower tax cost. Revenue grew by 21.5% to Rs 2,139.50 crore during the same period. Exide Industries: Subsidiary Exide Energy Solutions (EESL) has executed the lease cum sale agreement for procuring land parcel admeasuring 80 acres in Bengaluru with Karnataka Industrial Areas Development Board (KIADB). The land will be used to set up state-of-the-art green field multi-gigawatt Li-ion battery cell manufacturing facility for the new-age electric mobility and stationary application businesses in India. VIP Industries: The company registered a healthy growth in consolidated profit at Rs 69.10 crore in Q1FY23, on a low base in profit at Rs 2.53 crore in Q1FY22 that affected by second Covid wave. Revenue grew by 186.4% YoY to Rs 590.61 crore during the same period. Schaeffler India: The company recorded a 76.2% year-on-year growth in profit at Rs 225.75 crore in Q2CY22 driven by healthy topline and higher operating income. Gain on sale of chain drive business also supported bottom line. Revenue grew by 41.8% YoY to Rs 1,748.83 crore during the June 2022 quarter. EIH: The company clocked consolidated profit of Rs 65.86 crore for the quarter ended June 2022 on normalisation of business, against loss of Rs 114.25 crore in same period last year. In Q1FY22, numbers were affected by second Covid wave. Revenue grew by 314% YoY to Rs 394.3 crore in Q1FY23. Hindustan Aeronautics: HAL has signed contract worth over $100 million with Honeywell for HTT-40 Engines. The company will supply and manufacture 88 TPE331-12B engines/kits along with maintenance and support services to power the Hindustan Trainer Aircraft (HTT-40). #NIFTY50 #NIFTYBANK #HAL #TATAMOTORS #BIOCON

Equity And Option Trader

Clans India

Simple Trader

BIOCON BUY ABOVE 340 SL 296 CBSL TGT 360 380 400 420 440+++ POSITIONAL ADVANCE LEVEL #BIOCON

krivainfocom

Jaydip Dantani

*Stocks in News* Equitas Small Finance Bank: Veteran banker P N Vasudevan has resigned as the managing director and chief executive officer of Equitas Small Finance Bank, the lender informed the stock exchanges. Vasudevan, in his resignation letter, said he wants to devote his time towards social welfare through his public charitable trust. HPCL: State-run oil refiner and marketer Hindustan Petroleum Corporation posted a 34 percent decline in consolidated net profit in the March quarter to Rs 2,019 crore from Rs 3,061 crore in the year-ago period due to rise in total cost. Revenue for the quarter stood at Rs 1.07 trillion, up 24.2 percent from Rs 85,755 crore last year. Total cost rose 28 percent to Rs 1.05 trillion from Rs 81,717 crore a year ago. Operating margin for the quarter contracted sharply to 1.57 percent from 4.46 percent last year. Average gross refining margin during the year ended March 2022 was $7.19 per barrel as against $3.86 per bbl during the corresponding previous year. Godrej Consumer Products: Godrej Consumer reported a 1 percent fall in net profit for the March quarter to Rs 363 crore year-on-year as a slowdown in consumption and high commodity inflation weighed. Revenue rose 7 percent from a year ago to Rs 2,920 crore. Total cost rose 12 percent year-on-year to Rs 2,540 crore. Gland Pharma: Gland Pharma's net profit rose 10 percent to Rs 285.90 crore in the quarter ended March 2022 as against Rs 260.41 crore during the same quarter previous fiscal. Net sales rose 24.25 percent to Rs 1,103.01 crore as against Rs 887.75 crore a year ago. EBITDA margin contracted sharply to 35 percent from 40 percent year-on-year. Ashok Leyland: The company reported a 274 percent YoY jump in net profit at Rs 901.4 crore for the fourth quarter of FY22. Total income stood at Rs 8,744.3 crore during the quarter, up 24.9 percent against Rs 7,000.5 crore in the corresponding period of the preceding fiscal. Its truck market share for Q4 FY22 has improved to 30.6 percent against 28.9 percent in Q4 FY21, this is the highest market share seen in the last 11 quarters. Biocon: Subsidiary Biocon Biologics, and Viatris Inc. announced that Abevmy (bBevacizumab) is now available in Canada. Abevmy, co-developed by Biocon Biologics and Viatris, is a biosimilar to Roche's Avastin (Bevacizumab) and has been approved by Health Canada across four oncology indications. Eros International: Its board approved raising Rs 405 crore by issuing 13.50 crore warrants at a price of Rs 30 a share. #BIOCON #ASHOKLEY #GLAND #HINDPETRO #GODREJCP

TradeAdda

Carl Boy Crypto

ऐसे 18 स्टॉक्स जिसमें दिखेगा ऐक्शन और ट्रेड लेकर आप कर सकते हैं दमदार कमाई :- 1) CHENNAI PETROLEUM CORPORATION <GREEN> Dolly Khanna ने 263.15 रुपये/शेयर के भाव पर 10 लाख शेयर खरीदे हैं। 2) MRPL <GREEN> शेयर में आज भी तेजी जारी रहने की उम्मीद है। 3) TATA POWER <GREEN> Tata Power ने NAREDCO के साथ MoU किया। महाराष्ट्र में 5,000 EV चार्जिंग प्वाइंट लगाने के लिए MoU किया है। 4) TATA MOTORS <GREEN> कंपनी आज नई 7-सीटर इलेक्ट्रिक SUV लॉन्च करेगी। 5) VEDANTA <GREEN> Q4 में आय 27,874 करोड़ रुपये से बढ़कर 39,342 करोड़ रुपये रही, मुनाफा 7,261 करोड़ रुपये रहा। 6) SBI LIFE <GREEN> Q4 में मुनाफा 532 करोड़ रुपये से बढ़कर 672 करोड़ रुपये हुआ। कुल APE 4% बढ़कर 4,130 करोड़ रुपये हुई। 7) BIOCON <GREEN> Q4 में मुनाफा 283.9 करोड़ रुपये, आय 1,842 करोड़ से बढ़कर 2,409 करोड़ रुपये हुई। 8) HUHTAMAKI INDIA <GREEN> बोर्ड की महाराष्ट्र के अंबरनाथ में लीज होल्ड जमीन, बिल्डिंग को मोनिटाइज की मंजूरी मिली। 9) ADF FOODS <GREEN> प्रिफरेंशियल आधार पर जारी हुए वॉरंट के कनवर्जन पर विचार करने के लिए बोर्ड की बैठक होगी 10) SHRIRAM TRANSPORT FINANCE <GREEN> Q4 में मुनाफा 755 करोड़ रुपये से बढ़कर 1,086 करोड़ रुपये हुआ, NII बढ़कर 2,677 करोड़ रुपये हुई। 11) AMBUJA CEMENT (GREEN) Q1CY22 में मुनाफा 495 करोड़ रुपये रहा। आय 3,925 करोड़ और EBITDA मार्जिन 20.12% रही। 12) COLGATE (GREEN) कंपनी 21 रुपये/शेयर के भाव पर अंतरिम डिविडेंड देगी। कंपनी ने रिकॉर्ड डेट 25 मई तय किया है। 13) STERLITE TECH (RED) Q4 में 124 करोड़ रुपये के मुनाफे की जगह 22 करोड़ रुपये का घाटा हुआ। आय 1,582 करोड़ रुपये हुई। 14) BANK OF MAHARASHTRA (GREEN) Q4 में मुनाफा 165 करोड़ रुपये से बढ़कर 355 करोड़ रुपये हुआ। NII 1,383 करोड़ रुपये से बढ़कर 1,612 करोड़ रुपये हुई। Q4 में ग्रॉस NPA 4.73% से घटकर 3.94% हुआ जबकि नेट NPA 1.24% घटकर 0.97% हुआ। 15) PNB HOUSING (RED) Q4 में मुनाफा 130 करोड़ रुपये से बढ़कर 170 करोड़ रुपये हुआ। आय 1,810 करोड़ रुपये से घटकर 1,410 करोड़ रुपये हुई। 16) PERSISTENT SYSTEMS (GREEN) Nomura की खरीदारी की सलाह, लक्ष्य 5,500 रुपये/शेयर तय किया। 17) AXIS BANK (GREEN) MS की ओवरवेट की कॉल, लक्ष्य 910 रुपये/ शेयर तय किया। 18) IIFL FINANCE (GREEN) Q4 में मुनाफा 248 करोड़ रुपये से बढ़कर 321 करोड़ रुपये हुआ, आय बढ़कर 1,641 करोड़ रुपये हुई। #TATAPOWER #VEDL #SBILIFE #BIOCON #AXISBANK

Patil Trading

BUY BIOCON 380PE AT 6.25 SL 5 BELOW RISKY WHISKY 🌅 #biocon

Expert Opinions

5 Stocks to Keep in watch list for today... #BIOCON (F&O) #BPCL (F&O) #MANALIPETC #SPIC #BANG

Equity And Option Trader

Equity And Option Trader

BIOCON Critical support Buy near 338 or 325 Sl below 310 Target 350 400 #BIOCON

krivainfocom

ALERT: Now........BIOCON 350 CE @ 5.10 HIT........... Now you are GETTING Rs 2300 PROFIT AAY AMAZZA profit...!! DEKHLO KYA BOLA THA..ROCKET HAI CALL #BIOCON
K

King Harry

BIOCON FUT: BUY BIOCON FUT @ 342 TARGET- 357_361 Keep SL 337 #BIOCON
K

King Harry

OPTION_JACKPOT: BUY BIOCON 350 CE @ 4_4.10 TARGET_ 7.70_8.30 Keep SL 2.50 BUY KARO #BIOCON
K

King Harry

OPTION_JACKPOT: BUY BIOCON 350 CE @ 4_4.10 TARGET_ 7.70_8.30 Keep SL 2.50 BUY KARO #BIOCON
K

King Harry

YES JACKPTO CALL WHOLE PHARMA RUNNING BUY BIOCON FUT @ 341.80 TGT- 357_361 Keep SL 337 BUY BINDASSSSSSSSSS #BIOCON
K

King Harry

BIOCON 340 CE BUY ABOVE 7.20 NOTE : I AM NOT SEBI REGISTERED . ITS ONLY MY PERSONAL VIEW AND ONLY FOR EDUCATION PURPOSE NOT FOR TRADE...... #BIOCON

Manish Ramani

Geojit Financial Services target on BIOCON Date: 07-Feb-22 Broker: Geojit Financial Services Price @ Call: 392 Target: 460 Potential: 17.35% Recommendation: BUY

ReportBot

BEARISH STOCKS FOR THE DAY, SELL ON RISE: #HDFC #AXISBANK #BIOCON

The Market Crux

Sunil

Today Call Performance Missed mor gud entry even though end with some gud profits #BIOCON 💥 Great from 14.1 to 18.2 =9000+ #CANBK💥💥💥JACKPOT💥💥💥from 14.1 to 19.1+ =21000+✅ #HEROMOTOCO💥💥💥JACKPOT💥💥💥from 94.5to 137+ =12000+✅ #DLF 💥 Great from 17 to 21+ =7000+ #NIFTYBANK 1st entry given 90+ points, 2nd entry got 110+ points , 3rd entry hit trail sl , 4th entry 100+ points

Elavarasan

This view is based on volume, oi, delivery data & price action. ALL Posts are for educational purposes only & not any recommendation POSSIBLE BULLISH -> #BIOCON

vijay jaria

Aziz Khan

Hem Securities target on BIOCON Date: 22-Jan-22 Broker: Hem Securities Price @ Call: 377 Target: 422 Potential: 11.94% Recommendation: ACCUMULATE

ReportBot

Sharekhan target on BIOCON Date: 21-Jan-22 Broker: Sharekhan Price @ Call: 377 Target: 470 Potential: 24.67% Recommendation: BUY

ReportBot

ICICIdirect.com target on BIOCON Date: 21-Jan-22 Broker: ICICIdirect.com Price @ Call: 370 Target: 410 Potential: 10.81% Recommendation: HOLD

ReportBot

Gyanee

Q2) WHY DID BIOCON JUMP 5% IN A FALLING MARKET ? ANS:- BCOZ AFTER FOREIGN BROKER UPGREADED BIOCON TO OVERWEIGHT FROM "EQUALWEIGHT" WITH A TRG PRICE @ RUPEES 465 #BIOCON
B

boss

https://economictimes.indiatimes.com/markets/stocks/news/market-movers-why-did-biocon-jump-5-in-a-falling-market/articleshow/88998063.cms #BIOCON

NewsBot

#BAJFINANCE 270+💥💥 #BIOCON 15+ 💥💥💥JACKPOT 💥💥💥 #LTTS High 165+ #ICICIPRULI small sl mistakenly given it hit an then high 30+ #ONGC #TCS at entry level not moving

Elavarasan

Buy Biocon 380 call @ 5.5 (Near), Target 7/9, Stoploss PAID (Hold till 14/01/22)👌✌️ #BIOCON

Call Put Analyst

Buy Biocon 400 call @ 2.2, Target 2.8/3.5, Stoploss PAID (Hold till 13/01/22)💥✌️ #BIOCON

Call Put Analyst

Tmt View

JANUARY CONTRACT BUY BIOCON 370 CE AT CMP 13.55 TGT OPEN #BIOCON
F

FinanTree

KEEP A WATCH ON #BIOCON FUT NOW AT 371 SOME GOSSIP HEARD IN STREET FOR SOME ANNOUNCEMENT TODAY

IBN Services

#BIOCON Biocon🔥🔥🔥 Made high 389.70 All tgt hit Keep Booking Profit... Future Enjoy💵💵💵💵

Wealth Mentors

#BIOCON Biocon🔥🔥🔥 Made high 380 Tgt 2 hit Keep Booking Profit... Future Enjoy💵💵💵💵

Wealth Mentors

#BIOCON 8-12-2021 ... Buy @368-dips valid till Target 385-400 or Stop< 359

Cambist Analytics

Today Paid Calls Most of calls not activated #POWERGRID 💥💥💥JACKPOT 💥💥💥 10000+ #BIOCON hit sl , #ASHOKLEY hit 1st Tar Others not activated

Elavarasan

BUY BIOCON 370 CE ABOVE 15.10 #BIOCON

Perfect Traders

NewsBot-display-image
Reputation: 27,674  •  Nov 25 1:06 AM
Stocks in the news: Lupin, Biocon, PNB, Lauras Labs, PTC India and SJVN
The USFDA has issued 8 observations for the drug product facility and API facility at Mandideep. The US drug regulator has inspected company's Mandideep unit-1 facility during November 14-23, 2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 24 12:46 PM
Biocon Biologics allots equity shares worth Rs 2,205.63 crore to its parent
At the time of announcing the deal to acquire Viatris, BBL had said it would be through a cash payment of USD 2 billion, which would be funded through USD 800 million raised through equity infusion in BBL and the remainder by debt, additional equity or a combination
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 24 9:28 AM
Hold Biocon; target of Rs 290: ICICI Direct
ICICI Direct recommended hold rating on Biocon with a target price of Rs 290 in its research report dated November 15, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
Santosh Swing Trade Coach-display-image
Reputation: 330  •  Nov 24 5:46 AM

🔥This One picture=explains 100 words
Should I write more Guys?
Chartbusters - chart - 16805549
1 Like
2 Comments
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 21 8:53 AM
Buy Biocon; target of Rs 340: Sharekhan
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 340 in its research report dated November 15, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 21 3:21 AM
Buy Biocon, target price Rs 395: JM Financial
Biocon Ltd. key Products/Revenue Segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 21 11:43 AM
Hot Stocks | Here's why should bet on Sterlite Technologies, Biocon for short term
Sterlite Technologies has managed to traverse the key moving average of ‘200-day SMA’ (simple moving average) with some conviction after a long time, which construes a strong technical development.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 19 4:56 AM
More independent directors break into crore-plus pay club
Among the highest-paid independent directors is OP Bhatt, who is on the boards of Hindustan Unilever Ltd (HUL), Tata Consultancy Services, Tata Motors and Tata Steel, and Shikha Sharma, director of Ambuja Cements, Dr Reddy's Laboratories and Tech Mahindra.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 18 10:03 AM
Buy Biocon; target of Rs 340: Sharekhan
Sharekhan is bullish on Biocon has recommended buy rating on the stock with a target price of Rs 340 in its research report dated November 16, 2022.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 17 2:56 AM
Buy Biocon, target price Rs 395: JM Financial
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 34145.06 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 16 3:11 AM
Hot Stocks: Brokerages on Apollo Tyres, ONGC, Delhivery and Biocon post Q2 results
JPMorgan maintained an overweight rating on Apollo Tyres with a target price of Rs 370. The global investment bank slashed FY24-25 EPS by 2-3% to factor in slightly lower volume growth in India.
The Economic Times
Like
Comment
Share
Add a comment
Valid CHARTS -display-image
Reputation: 3,327  •  Nov 15 3:07 AM
3 Likes
5 Comments
Share
Add a comment
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 15 1:31 AM
Biocon Q2 Results: Net profit drops 66% YoY to Rs 47 cr due to exceptional items
Total revenues rose 23% YoY for Q2FY23 at Rs 2,384 crore compared to Rs 1,945 crore in Q2FY22
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 14 3:53 AM
Biocon Q2 results: Consolidated net profit falls 66% to Rs 47 crore, revenue rises 26%
Biocon Biologics Limited saw 34 percent year-on-year increase in revenue at Rs 997 crore.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 14 3:41 AM
Biocon Q2 Results: Net profit drops 66% YoY to Rs 47 cr due to exceptional items
Total revenues rose 23% YoY for Q2FY23 at Rs 2,384 crore compared to Rs 1,945 crore in Q2FY22
The Economic Times
Like
Comment
Share
Add a comment
Patil Investment-display-image
Reputation: 1,792  •  Nov 13 4:15 AM

Follow more hidden update:
Before Big move catch it and sleep 🤗
Must Check Our Biocon Chart : Is it bottom.??
Learn more unique secret strategy ⚡
Biocon is triggered bottom and reversed to uptrend. Learn this type unique secret strategy ⚡
Now biocon is ready for big ......read more
Chartbusters - chart - 15860159
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Nov 13 2:31 AM
Economic data, US mid-term elections, FII action on D-Street traders’ radar next week
The prevailing positive global sentiment is set to drive equities further up in the coming week, but some analysts recommend adopting a cautious approach. “With benchmark indices touching 52 week highs and the Nifty Bank index touching new all time highs, we remain cautiously optimistic, advising investors to be agile and aware of the recent and upcoming macroeconomic events in order to make dynamic decision-making both ways,” said Anmol Das, HoR, Teji Mandi.
The Economic Times
Like
Comment
Share
Add a comment
Sameer -display-image
Reputation: 8,127  •  Oct 27 3:55 AM

27-10-22
BIOCON BUY NOV CE 280 (Intraday)
only above 8

Like
3 Comments
Share
Add a comment
Traders Seventh Heaven-display-image
Reputation: 737  •  Oct 19 8:18 AM

#BIOCON near a BIG Resistance 273-75 can test 255-240 level soon
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 17 4:48 AM
Biocon Biologics inks out-licensing agreement with Yoshindo Inc
Under the terms of this deal, Japan-based Yoshindo gets exclusive commercialisation rights in Japan for Ustekinumab and Denosumab -- developed and manufactured by Biocon Biologics -- for an addressable market opportunity of USD 700 million, Biocon Biologics said in a statement.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 14 5:41 AM
Retail, industrials to do well; pharma only contra pack in market: Sandip Sabharwal
"My main worry is the imminent slowdown in the western economies and what impact that will have on IT outsourcing. If these companies remain totally immune to that, then that call was totally wrong and these could become huge performers next year. But I would not bet on it. So what this result commentary and the buyback does is that it reduces downside risk. But it does not open up a very significant upside potential in my view."
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 8:56 AM
Hot Stocks: Brokerages on Asian Paints, HCL Tech, Wipro, Maruti, Biocon and ITC
BofA maintained a buy call on Biocon with a target price of Rs 415. The brokerage sees a positive trend in the existing portfolio and earnings catalyst in the next few quarters.Stock's recent underperformance provides an attractive buying opportunity, it said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 7:46 AM
Hot Stocks: Brokerages on Asian Paints, HCL Tech, Wipro, Maruti, Biocon and ITC
BofA maintained a buy call on Biocon with a target price of Rs 415. The brokerage sees a positive trend in the existing portfolio and earnings catalyst in the next few quarters.Stock's recent underperformance provides an attractive buying opportunity, it said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 7:26 AM
Buy Biocon, target price Rs 395: JM Financial
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 31515.75 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 6:21 AM
Hot Stocks: Brokerages on Asian Paints, HCL Tech, Wipro, Maruti, Biocon and ITC
BofA maintained a buy call on Biocon with a target price of Rs 415. The brokerage sees a positive trend in the existing portfolio and earnings catalyst in the next few quarters.Stock's recent underperformance provides an attractive buying opportunity, it said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 6:11 AM
Hot Stocks: Brokerages on Asian Paints, HCL Tech, Wipro, Maruti, Biocon and ITC
BofA maintained a buy call on Biocon with a target price of Rs 415. The brokerage sees a positive trend in the existing portfolio and earnings catalyst in the next few quarters.Stock's recent underperformance provides an attractive buying opportunity, it said.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 5:51 AM
Buy Biocon, target price Rs 395: JM Financial
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 31515.75 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 13 5:26 AM
Buy Biocon, target price Rs 395: JM Financial
Biocon Ltd., incorporated in the year 1978, is a Large Cap company (having a market cap of Rs 31515.75 Crore) operating in Pharmaceuticals sector.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 7 2:43 AM
Europe points out deficiencies at Biocon’s Bengaluru bulk drug plant
While no deficiencies were marked as critical, one was categorised as major, the company said in a stock exchange filing.
Moneycontrol
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Oct 7 11:46 AM
Tube Investment, ABB, Varun Bev, IHCL likely to enter MSCI index
Tube Investments of India, which rallied 65% in the last six months, could see an inflow of $200 million, while Indian Hotels and Varun Beverages could see inflows of $190 million and $180 million, respectively.
The Economic Times
Like
Comment
Share
Add a comment
Patil Investment-display-image
Reputation: 1,792  •  Oct 3 3:39 AM
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 28 11:31 AM
European business chill may hurt Indian companies, too
With the British pound tumbling to its all-time low against the US dollar amid a gloomy outlook for Europe, analysts expect the earnings of companies with business interests in the region to be under pressure.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 22 3:41 AM
Market cap of Adani Group stocks equals 83 midcaps or 858 smallcaps
As a result of the massive surge in share prices, the Ahmedabad-based businessmans wealth grew 116 per cent in the last one year and in absolute terms, he earned Rs 5,88,500 crore, according to IIFL Wealth Hurun India Rich List 2022.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 21 7:41 AM
Falguni Nayar pips Kiran Mazumdar, Rekha Jhunjhunwala to become richest Indian woman
Falguni Nayar & family's wealth rose Rs 30,000 crore during the year and her cumulative wealth increased 345 per cent and stood around Rs 38,700 crore, data suggested. Among the top 10 gainers in terms of wealth addition, Nayar stood at the fifth spot and was the only female on the list. She followed the likes of Gautam Adani, Mukesh Ambani and Cyrus S Poonawalla.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 19 6:06 AM
Buy Biocon, target price Rs 395: JM Financial
For the quarter ended June 30, 2022, the company has reported a consolidated total income of Rs 2217.40 crore, down 10.45 per cent from last quarter total income of Rs 2476.10 crore and up 22.66 per cent from last year same quarter Total Income of Rs 1807.80 crore.
The Economic Times
Like
Comment
Share
Add a comment
Being Trader-display-image
Reputation: 23,977  •  Sep 14 3:49 AM

Round Bottom and consolidation breakout
with supportive volumes and
RSI is looking strong as it not going below 60
on hourly time frame
Chartbusters - chart - 12473749
2 Likes
Comment
Share
Add a comment
Market Buzz-display-image
Reputation: 1,375  •  Sep 13 8:02 AM

Short Term Equity Trading Tips(Hold 6months to 1 year)
1. Buy #NAZARA technologies @ 750-780
StopLoss: 650 ; Target:800/850/900+
2. Buy #BRIGADE Enter.Ltd @545-580
Stopploss:500; Target: 585/600/620+
3. Buy #LEMONTREE hotels ltd @CMP
......read more
Like
2 Comments
Share
Add a comment
Being Trader-display-image
Reputation: 23,977  •  Sep 9 3:26 AM
3 Likes
Comment
Share
Add a comment
Being Trader-display-image
Reputation: 23,977  •  Sep 9 3:25 AM

looks good above @315
watch it says all
same pattern on price and RSI
Chartbusters - chart - 12337758
1 Like
1 Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 7 6:06 AM
Delhi High Court grants bail to three in Biocon Biologics case
They are S Eswara Reddy, joint drug controller at national drug regulator Central Drugs Standard Control Organisation (CDSCO), L Praveen Kumar, head of national regulatory affairs at Biocon Biologics, and Dinesh Dua, director at Synergy Network India Private Ltd."Though undoubtedly the offence alleged to have been committed (if proved) by the applicants is grave, the trial in the matter would take ample time," Justice Anu Malhotra said while granting them bail.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 6 2:31 AM
Biocon sells 5.4 pc stake in arm Syngene International
The scrip of Syngene International has settled 2.38 per cent lower at Rs 565 apiece on the BSE.ICICI Prudential Mutual Fund was among the entities that lapped up the company's shares.As of June year, of the promoters' holding of 70.29 per cent, Biocon held a 69.99 per cent stake in Syngene, the shareholding pattern with the exchange showed
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 6 8:51 AM
Delhi HC grants bail to three in Biocon biologics bribery case
The Delhi High Court on Tuesday granted bail to three accused in connection with the Biocon Biologics-Central Drugs Standard Control Organisation (CDSCO) bribery case being probed by the Central Bureau of Investigation. While granting relief, the high court opined that the alleged offences in question were grave.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 6 4:16 AM
Stock market update: Stocks that hit 52-week highs on NSE
Dreamfolks Services Ltd., Rossell India, Sakthi Sugars, Aster DM Health and Dangee Dums, hit their fresh 52-week highs at 10:45AM.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 2:16 AM
Ahead of Market: 10 things that will decide stock action on Friday
Nagaraj Shetti, Technical Research Analyst, HDFC Securities, said the short-term trend remains range bound with high volatility. “There is a possibility of an upside bounce from near the lower support of 17,350-17,300 levels in the short term. Immediate resistance is placed at 17,650 levels.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 10:31 AM
Sensex falls! These stocks fell 5% or more in Thursday's session
In the Nifty pack, 13 stocks closed in the green, while 37 stocks ended in the red.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 10:01 AM
Stock market update: Stocks that hit 52-week highs on NSE in today's trade
Reliance Power, Paramount Comm, Reliance Infra, Aaron Industries and Rossell India, hit their fresh 52-week highs during the day.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 9:46 AM
Sensex falls! But these stocks gained over 10% on BSE
In the Nifty 50 index, 13 stocks ended in the green, while 37 stocks closed in the red in today's trade.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 9:36 AM
Stock market update: Stocks that hit 52-week lows on NSE in today's trade
Hindalco, RIL, ONGC, TCS and SBI Life were among the top losers on NSE in today's trade.
The Economic Times
Like
Comment
Share
Add a comment
NewsBot-display-image
Reputation: 27,674  •  Sep 1 8:01 AM
Syngene to benefit from rupee depreciation, rising demand for research & manufacturing services: CEO Jonathan Hunt
Syngene has raised the revenue guidance for FY23 from mid-teens to high teens due to significant depreciation of rupee against the dollar and signing up new contracts. Rupee depreciated almost 5% since April 1 against the dollar.
The Economic Times
Like
Comment
Share
Add a comment